Savara Inc. Board of Directors

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.

Mr. Matthew Pauls J.D., M.B.A.

Mr. Matthew Pauls J.D., M.B.A.

Chairman & CEO

Ms. Kate McCabe J.D.

Ms. Kate McCabe J.D.

Senior VP & General Counsel

Mr. Charles LaPree

Mr. Charles LaPree

Senior Vice President of Global Regulatory Affairs & Quality Assurance

Mr. Robert Lutz M.B.A.

Mr. Robert Lutz M.B.A.

Chief Operating Officer

Mr. Scott L. Wilhoit

Mr. Scott L. Wilhoit

Executive Vice President of Global Commercial

Dr. Peter Clarke Ph.D.

Dr. Peter Clarke Ph.D.

Executive Vice President of Global Technical Operations

Ms. Anne Erickson

Ms. Anne Erickson

Chief Business Officer

Mr. David L. Lowrance CPA

Mr. David L. Lowrance CPA

CFO, Chief Administrative Officer & Secretary

Brian Maurer

Brian Maurer

Head of Clinical Operations

Dr. Raymond Dennis Pratt FACP, M.D.

Dr. Raymond Dennis Pratt FACP, M.D.

Chief Medical Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments

Comment created.